Circadian rhythm: The hidden “puppet master” behind musculoskeletal disorders Authors: Sheng Zhong, Yuan Cheng, Fadong Li, Dingpeng Li, Xudong Chang, Bo Zhang, Peng Qi, Ning Li, Xingwen Xie Published: 2026 ABSTRACT Circadian rhythm (CR), regulated by the central biological clock in the hypothalamus and synchronized with local clocks in peripheral tissues, orchestrates the physiology of localized tissues in response to the periodic rhythmic variations of the environment. Environmental cues and behavioral factors, such as light exposure, feeding, and exercise, can synchronize or desynchronize these rhythms, and abnormalities can lead to disruption of the human CR. Certain modern behaviors, such as traveling across time zones, shift work, and irregular eating patterns, disrupt the body's natural CR, thereby potentially contributing to the development of musculoskeletal disorders through multiple pathways. In this review, we summarize the role of CR in the physiology of the musculoskeletal system—encompassing bone, cartilage, tendons, and muscles—alongside the mechanisms by which CR disruption contributes to various musculoskeletal disorders. Additionally, we discuss interventions for treating musculoskeletal disorders based on CR, including resetting biological clocks or optimizing medication administration times.The translational potential of this articleA comprehensive understanding of the role of CR in the physiology and pathology of the musculoskeletal system offers significant therapeutic and preventative opportunities for musculoskeletal disorders, holding considerable importance for advancing the prevention and treatment of such conditions. Introduction CR are regular patterns of physiological activity and behavior developed by humans and animals to adapt to the Earth's rotation, closely linked to eating-fasting, activity-rest, and sleep-wake cycles[[1], [2], [3]]. The complete CR system (also known as the biological clock system) comprises a master clock located in the suprachiasmatic nucleus (SCN) of the hypothalamus, non-SCN biological clocks within the brain, and peripheral sub-clocks (also termed CR oscillators) distributed throughout peripheral tissues [4,5]. The master clock synchronizes peripheral sub-clocks by driving rhythmic physiological processes and generating signals that regulate neuronal activity and hormone release [6]. The cellular autonomous molecular clocks of peripheral tissue regulate local physiology and metabolism by generating tissue-specific rhythms to meet daily demands [7]. The master clock and peripheral sub-clocks work in tandem to maintain the body's normal physiological functions. Certain environmental cues and behavioural factors, known as zeitgebers or circadian entrainment factors, such as light exposure, feeding, and exercise, can synchronize or desynchronize these rhythms [8]. The term ‘zeitgeber’ comes from German and means ‘time signal’. It refers to an external signal that provides a temporal cue, enabling the body's internal clock to synchronize with the 24-h day-night cycle [8]. Circadian entrainment facilitates temporal alignment between the internal biological clock and the external environment's 24-h day-night cycle, optimizing metabolism and energy allocation to accommodate daily variations in physiological demands [8,9]. A healthy CR requires the circadian system to maintain optimal function, rhythmicity, and coordination within light-dark cycles, thereby sustaining physiological and behavioural homeostasis. The human musculoskeletal system also possesses an intrinsic cellular CR, regulated both by external environmental cues and by the internal master clock [10]. The molecular clock within cells enables tissues to anticipate rhythmic changes in their local environment and specific demands, exhibiting tissue specificity [11]. All components of the musculoskeletal system—including bone, cartilage, skeletal muscle, and tendons—possess tissue-specific rhythmic systems that maintain tissue homeostasis [7,12]. These oscillating genes within the tissue (clock-regulating genes) encompass key tissue-specific transcription factors and characteristic structural proteins, as well as genes involved in fundamental metabolic pathways within that tissue[[13], [14], [15]]. Therefore, the local tissue clocks within the musculoskeletal system play a crucial role in tissue physiology and disease. Under physiological conditions, the phase of circadian gene expression coupled with the animal's rest-activity cycle is beneficial for maintaining homeostasis in the musculoskeletal system. However, CR dysregulation impairs endocrine, inflammatory and biomechanical determinants of musculoskeletal health, accelerating the progression of musculoskeletal disorders. Research has revealed that multiple musculoskeletal disease phenotypes, including osteoporosis, arthritis, muscle wasting/atrophy, and tendinitis/tendinosis, are closely associated with disruptions to CR[[16], [17], [18], [19]]. Therefore, restoring the intrinsic CR of the musculoskeletal system and synchronizing it with other tissues throughout the body and the external environment will be beneficial for the management of musculoskeletal disorders. In this review, we summarize the role of CR in musculoskeletal physiology and elucidate the mechanisms through which circadian disruption contributes to various musculoskeletal disorders. Furthermore, we explore circadian-based interventions for treating musculoskeletal conditions, including resetting the biological clock or optimizing the timing of medication administration. A deeper understanding of CR in the physiology and pathology of the musculoskeletal system presents significant opportunities for the treatment and prevention of such disorders, which is of great importance for advancing the management of related diseases. Molecular mechanism and zeitgebers of CR Molecular mechanisms of CR The 24-h circadian clock in mammals is regulated by a network of central and peripheral oscillators that collectively govern cellular and systemic rhythms (including the musculoskeletal system) (Fig. 1) [20]. Most biological clock factors regulating the CR are transcription factors or nuclear hormone receptors with limited half-lives, enabling them to oscillate and turnover daily. At the molecular level, the CR is regulated by a transcriptional-translational feedback loop (TTFL) driven by core clock genes, which operates in a 24-h cycle [21]. This loop comprises a forward regulatory arm (involving the core clock genes CLOCK and BMAL1), a reverse regulatory arm (involving the core clock genes PERs and CRYs), and an auxiliary stabilizing loop (involving the nuclear receptors REV-ERBs and RORs) [12]. As the waking period commences, the BMAL1 and CLOCK genes undergo transcription and translation, forming the BMAL1/CLOCK heterodimer [22]. Subsequently, the BMAL1/CLOCK heterodimer binds to the E-box response elements within the promoter regions of PER and CRY genes, thereby regulating their expression [23]. PER and CRY proteins gradually accumulate during the day, heterodimerize, and are transported to the nucleus at night to induce negative feedback inhibition of BMAL1 and CLOCK transcriptional activity, thereby suppressing their own transcription [23,24]. Subsequently, the degradation of PER and CRY proteins will alleviate this negative feedback, thereby enabling the circadian clock to initiate a new cycle. This process forms a negative feedback loop with periodic oscillations. Additionally, an auxiliary feedback loop composed of nuclear receptors REV-ERBs and RORs also assists this feedback loop in stabilizing the core circadian circuit [25]. Their transcription is activated by the BMAL1/CLOCK heterodimer, which can bind to the RRE element within the BMAL1 promoter to either inhibit or activate BMAL1 transcription [25]. Furthermore, the DBP protein can bind to the D-box, which is another circadian promoter element, thereby driving the expression of other clock genes [26]. NFIL3 can compete with DBP to inhibit the D-box element, thereby forming a bidirectional regulatory network [26]. This provides an additional layer of regulation for the transcription of ROR family genes.Fig. 1Schematic of the CR molecular machinery and entrainment factors. The circadian rhythms within mammalian organisms are jointly regulated by a network of central and peripheral oscillators, which collaboratively govern cellular and systemic rhythms (including those of the musculoskeletal system). Light exposure, feeding and exercise are entrainment factors for CR. At the molecular level, the CR is regulated by a transcriptional-translational feedback loop (TTFL) driven by core clock genes, which operates in a 24-h cycle. SCN: suprachiasmatic nucleus. Figures were created with BioRender.com. Schematic of the CR molecular machinery and entrainment factors. The circadian rhythms within mammalian organisms are jointly regulated by a network of central and peripheral oscillators, which collaboratively govern cellular and systemic rhythms (including those of the musculoskeletal system). Light exposure, feeding and exercise are entrainment factors for CR. At the molecular level, the CR is regulated by a transcriptional-translational feedback loop (TTFL) driven by core clock genes, which operates in a 24-h cycle. SCN: suprachiasmatic nucleus. Figures were created with BioRender.com. The rhythmic expression of clock-controlling genes is primarily driven by the aforementioned TTFL. By regulating various stages of gene expression, such as transcription, splicing, termination, translation, and post-translational modifications, control of CR can be achieved [27,28]. In different organisms, the core clock mechanism regulates nearly half of all expressed genes in a species-specific manner [29]. However, it remains unclear how circadian mechanisms interact with tissue-specific transcription factors to mediate broader transcriptional control. Certain studies have revealed the co-localisation of tissue-specific transcription factors and clock factors at promoters and enhancers, which has deepened our understanding of this mechanism[[30], [31], [32]]. For instance, within muscle tissue, the muscle-specific transcription factor MYOD1 has been found to colocalise with BMAL1/CLOCK in myonuclei, where they synergistically regulate the expression of muscle-specific clock control genes through tandem E-box promoter elements [33]. Other research findings suggest that the transcriptional regulation of tissue-specific genes by circadian mechanisms may be associated with changes in chromatin structure [31,34]. Further exploration is required into the tissue-specific mechanisms underlying CR transcription. Environmental and behavioral zeitgebers in musculoskeletal regulation The synchronization and regulation of endogenous CR within the musculoskeletal system is facilitated by a variety of upstream external signals, collectively referred to as 'zeitgebers'. Based on their origin and regulatory characteristics, the primary zeitgebers involved in regulating musculoskeletal rhythms can be classified into environmental signals (such as light, ambient temperature and noise) and behavioural signals (such as exercise and eating). Among environmental signals, light is the strongest zeitgeber for CR synchronization. Light directly adjusts endogenous biological clock rhythms through the retinal-hypothalamic-SCN-pineal pathway [8,35,36]. Changes in the duration of light exposure (such as when traveling across time zones or working shifts) can cause the timing of the biological clock rhythm to shift backwards or forwards, thereby triggering ‘jet lag’ or ‘shift work syndrome’ [37,38]. Research indicates that morning light exposure promotes phase advancement, while nighttime light exposure (especially between 11:00 pm and 3:00 am) tends to cause phase delay [8,37,39]. Brown et al. have proposed recommendations for optimal light exposure during daytime, evening, and night-time hours indoors to better support the physiology of healthy adults [37]. It is recommended that bright light exposure be maintained during the day, including natural daylight or indoor lighting, to support alertness and cognitive function [37]. However, exposure to bright light should be avoided in the evening, particularly short-wavelength light, as this can cause a phase delay in the central biological clock rhythm [37,38]. Furthermore, ambient temperature and noise can also influence the human circadian rhythm by affecting sleep-wake patterns. Münzel et al. indicate that nighttime noise disrupts sleep architecture, leading to fragmented sleep, and that this sleep disturbance further impacts physiological functions related to the human CR [40]. This phenomenon may primarily occur by altering sleep–wake patterns, thereby affecting the timing of exposure to light and other zeitgebers, thus impacting the CR system. Behavioural factors, including time of feeding and exercise, may also serve as ‘zeitgeber’ for both central and peripheral circadian clocks[[41], [42], [43]]. Early studies in human and animal models indicate that meal timing and food composition are zeitgebers for the CR, which can entrain to food intake [44]. Research confirms that hormones regulating appetite (such as ghrelin) and ingested nutrients (such as glucose) function as peripheral circadian clock zeitgebers within organs involved in metabolism [35]. Time-restricted feeding uses ‘nutrient intake’ as a strong zeitgeber to regulate the expression of circadian genes (such as Clock, Bmal1, Per1/2, Cry1/2) in peripheral organs, thereby realigning peripheral clocks like the liver with the central master rhythm [45]. Moreover, the timing of feeding has also been demonstrated to exert an influence on behavioural rhythms. For instance, in the case of daytime feeding in mice or rats, the phenomenon of ‘food anticipatory activity’ has been observed [46]. This is characterized by periods of wakefulness and foraging behaviour that occur in anticipation of feeding time, regardless of the presence or absence of the light-dark cycle [46]. When eating patterns become disordered (such as nighttime eating or irregular meals), peripheral clocks become desynchronized from the central clock, which is associated with a greater risk of metabolic diseases (such as obesity and type 2 diabetes) [47]. Moreover, a recent observational study in humans has found that both skipping breakfast and eating dinner late are independently associated with a higher risk of osteoporotic fractures [48]. This may be because skipping breakfast causes a “nutritional interruption” in the bones, leading to insufficient intake of vitamin D and calcium; whereas eating dinner too late disrupts the bones' biological clock, causing elevated cortisol levels that inhibit the function of osteoblasts. Furthermore, exercise—including both voluntary and involuntary forms—can synchronize the rhythms of animal behaviour and influence both central and peripheral circadian clocks [43]. Research has demonstrated that the timing of exercise affects time-phase shifts (by adjusting the ‘phase’ of biological rhythms, causing physiological functions to “advance” or “delay” along the temporal axis) [49]. An observational study in humans reveals that exercise performed at times corresponding to 7:00 am and between 1:00 pm and 4:00 pm may result in an advancement of the central biological clock's phase. In contrast, exercise during periods equivalent to 7:00 pm to 10:00 pm may lead to a phase delay [50]. This time-phase shift effect varies according to different individuals' original chronotypes [49]. Chronotype classifications encompass two distinct categories: morning and evening types [8]. Morning individuals possess an early or advanced internal rhythm, while evening individuals exhibit a late or delayed internal rhythm. For late chronotypes, both morning and evening exercise cause phase advancement [49]. However, in morning chronotypes, morning exercise leads to phase advancement, while evening exercise causes phase delay [49]. Within the musculoskeletal system, the mechanical loading and unloading induced by the exercise-rest cycle are of paramount importance for maintaining both the structural integrity and functional homeostasis of the musculoskeletal system. The coupling of daily loading and unloading physiology with associated metabolic changes may be a crucial component of the musculoskeletal system's physiology and homeostasis. Exercise helps synchronize the CR in peripheral tissues such as skeletal muscle by influencing the expression of core circadian clock genes in these tissues [51,52]. CR within the musculoskeletal system In summary, the preceding sections have elucidated the core mechanisms of the circadian clock and its upstream regulatory factors at the molecular level. Building on this theoretical foundation, this section will systematically summarize the specific circadian oscillatory characteristics of musculoskeletal tissues (including bone, cartilage, tendons and muscle). By analysing the unique rhythmic phenotypes of each tissue type and the function of their circadian clocks, we aim to elucidate the physiological roles of core rhythmic mechanisms within different cellular and tissue microenvironments, thereby establishing the intrinsic link between molecular regulatory mechanisms and physiological phenotypes. CR in bone All components of the musculoskeletal system—including bone, cartilage, skeletal muscle, and tendons—possess tissue-specific rhythmic systems that maintain tissue homeostasis [7,12](Fig. 2). The CR of the bone is a complex network jointly regulated by clock genes, hormones, and environmental signals. The core function of the CR is to maintain the balance between osteoblasts and osteoclasts, thereby ensuring bone homeostasis. The local CR within the bone plays a crucial role in bone growth, mineralization, remodelling, and repair. Transcriptomic characterization of bone tissue from mice maintained under a 24-h light-dark cycle revealed that genes encoding core circadian clock proteins, those involved in bone morphogenetic protein (BMP), fibroblast growth factor (FGF) signaling, Wnt signaling, and various procollagen subtypes exhibited circadian oscillations [14]. This highlights the scope of CR influence on skeletal physiology. Moreover, all cell types in bone tissue exhibit CR, but different cell types demonstrate distinct rhythms in the expression of functional activities [21]. For example, findings from in vitro studies indicate that the expression levels of the osteoclast function markers Ctsk and Rankl were highest at the start of the light period, while the expression of the osteoblast marker Opg was lowest [53]. In contrast, c-Fos expression in osteocytes peaked during the mid-dark period [53]. This rhythmic alternation prevents bone damage caused by the “synchronous hyperactivity” of osteogenesis and osteoclastism, or the stagnation of bone remodelling resulting from their “synchronous inhibition”, thereby being crucial for maintaining bone mass. Concurrently, extensive research indicates that the majority of bone metabolism markers, including bone formation markers such as osteocalcin (OCN), bone-specific alkaline phosphatase (BALP) and procollagen type I N-terminal propeptide (PINP), as well as resorption markers such as the cross-linked carboxyl-terminal telopeptide of type I collagen (ICTP), carboxy-terminal telopeptide of type I collagen (CTx) and type I collagen N-terminal cross-linked peptides (NTx), exhibit circadian rhythmic oscillations [54,55]. This suggests that bone tissue, as a dynamically remodelling metabolic organ, exhibits a balance between bone formation (predominantly driven by osteoblasts) and bone resorption (predominantly driven by osteoclasts) that is not random but precisely regulated by CR.Fig. 2Tissue-specific CR in the musculoskeletal system. All components of the musculoskeletal system—including bone, cartilage, skeletal muscle, and tendons—possess tissue-specific rhythmic systems that maintain tissue homeostasis. Clock genes regulate cellular functions within tissues, thereby maintaining tissue homeostasis. Figures were created with BioRender.com. Tissue-specific CR in the musculoskeletal system. All components of the musculoskeletal system—including bone, cartilage, skeletal muscle, and tendons—possess tissue-specific rhythmic systems that maintain tissue homeostasis. Clock genes regulate cellular functions within tissues, thereby maintaining tissue homeostasis. Figures were created with BioRender.com. CR in bone tissue are also regulated by multiple factors. On the one hand, entrainment factors—including light exposure, feeding, exercise, and temperature—can influence the CR of local bone tissue through the sympathetic nervous system and various hormones [21]. On the other hand, the CR of bone tissue can independently respond to environmental signals such as mechanical loading, nutrients (such as vitamin D), and inflammatory factors, maintaining their rhythms without requiring central nervous system drive [[56], [57], [58]]. Therefore, the molecular biological clock does not operate in isolation, but rather integrates signals throughout the body via a “hormone-metabolism-nervous system” network, thereby regulating the synchrony and intensity of CR. CR in cartilage Within cartilage tissue, the physiological functions of chondrocytes—such as matrix synthesis/degradation, repair capacity, and inflammatory responses—are regulated by their intrinsic CR [15,59]. Time-series microarray analysis of mouse cartilage tissue has revealed that multiple genes involved in the pathways of extracellular matrix (ECM) catabolism, ECM anabolism, apoptosis, and oxidative stress exhibit rhythmic expression patterns [15]. Under physiological conditions, cartilage tissue undergoes a daily cycle of activity and rest, resulting in circadian fluctuations in the biochemical and biophysical environment of chondrocytes [60]. During the day, cartilage tissue must withstand high loads and meet high metabolic demands; at night, it experiences low loads and undergoes tissue repair [61]. The “synthesis-degradation” rhythm of normal cartilage ensures that matrix renewal and repair primarily occur during the night (resting period), while daytime activity is dominated by mild degradation and the clearance of metabolic waste. Research findings have indicated that the hallmark genes associated with cartilage formation demonstrate CR oscillation patterns [62]. Specifically, the synthetic activity of chondrocytes peaks at night and reaches its lowest point during the day, while their degradative activity exhibits an inverse rhythm, peaking during the day and reaching its lowest point at night. Moreover, the synchronization of the biological clock has been demonstrated to significantly enhance cartilage matrix production and elevate the expression levels of SOX9, ACAN, and COL2A1 genes, thereby promoting cartilage maturation [62]. Concurrently, core components of the cartilage matrix in serum—such as cartilage oligomeric matrix protein, hyaluronic acid, aggregated proteoglycans, and type II collagen—also exhibit circadian rhythmicity, reinforcing the circadian nature of cartilage physiology [63,64]. Analysis of phosphorus and calcium components in rat tibiae indicates that cartilage mineralization in rats occurs predominantly during the night [65]. This pattern parallels the physiological timing of bone mineralization while contrasting with the midday peak observed in collagen synthesis [65]. Circadian fluctuations in the joint microenvironment—including mechanical loading, nutrient supply, and inflammatory factors—can influence the biological clock of chondrocytes, ultimately affecting cartilage homeostasis and disease progression [57,66,67]. The clock gene has been identified as a mechanosensitive gene, and its expression is downregulated by mechanical stress in cartilage [68]. Consequently, the cartilage circadian clock may be subject to synchronization regulation by daily activity rhythms. Moreover, a marked reduction in the amplitude of circadian oscillations was also observed in aged cartilage tissue [15]. When these genes regulating cartilage homeostasis lose their rhythmic expression, it may significantly impact susceptibility to joint diseases. CR in skeletal muscle There is ample evidence of the time-of-day-dependent variation in muscle physiology and neuromuscular performance [69]. The intrinsic CR in skeletal muscle coordinates the timed expression of multiple genes involved in muscle growth, development, metabolism, and repair processes[5,7,[70], [71], [72]]. The CR of skeletal muscle regulates insulin sensitivity and glucose metabolism, providing the energy foundation for skeletal muscle to respond to daily rest-activity patterns [73]. A normal CR has also been demonstrated to promote an increase in skeletal muscle protein content, improve mitochondrial quality, and stimulate cellular regeneration and repair, thereby preventing or mitigating skeletal muscle atrophy [18]. Moreover, the skeletal muscle circadian clock influences periodic variations in muscular function, such as muscle strength and power, which typically peak in the evening hours [74,75]. Skeletal muscle-specific circadian clock genes that exhibit diurnal rhythms include myogenic differentiation gene 1 (Myod1), uncoupling protein 3 (Ucp3), and myosin heavy chain 1 (Myh1) [10]. Their functions are related to myogenic differentiation, protein metabolism, and myofibrillar organisation respectively [10]. The observation that muscle-specific genes are influenced by CR underscores the significance of temporal considerations in activities such as physical exercise. Scheduled exercise can entrain the circadian clocks in skeletal muscles [76]. That is, the rhythm of gene expression in skeletal muscle may be regulated by locomotor activity [76]. Exercise can profoundly influence muscle adaptation and performance by interacting with these rhythmic processes. Therefore, maintaining a well-regulated muscle CR is essential for promoting muscle health and optimizing performance. Conversely, disruption of the muscle CR can impair muscle function and self-repair capabilities, leading to a decline in muscle mass and strength (as observed in muscular dystrophy) [5,71,72]. CR in tendons There is a complex bidirectional relationship between tendon ECM dynamics and CR regulation. The circadian clock within tendons regulates the daily rhythmic synthesis of collagen and the abundance of small-diameter collagen fibers (∼50 nm) within the ECM [77]. It maintains a daily replenishment of the collagen reservoir by temporally regulating protein secretion, which enables the repair of collagen fibers in high-loaded tissues [78]. Research on the CR of mouse tendons has revealed that the ECM of murine tendon cells exhibits circadian variations in ultrastructure (fluctuations in the number of small-diameter collagen fibers) and viscoelastic properties (higher energy dissipation and faster relaxation during nocturnal cyclic loading) [78,79]. These changes in the extracellular matrix collectively represent the ‘chronomatrix’ in tendon. The tendon ‘chronomatrix’ is a dynamic, rapidly renewing submatrix regulated by the CRs of tendon cells. It is rich in short-lived, fine-diameter type I collagen and works in concert with the persistent permanent matrix to maintain the mechanical homeostasis of the tendon. Moreover, the circadian clock of tendons regulates the sequential and rhythmic expression of multiple clock-controlled genes involved in collagen synthesis. For example, the entire process from transcription and translation of Col1a1 and Col1a2 genes to post-translational modifications is linked to the tendon circadian clock [78]. This clock-regulated collagen is believed to be part of a multicomponent sacrificial ‘chronomatrix’ that coexists with the more permanent bulk collagen and may protect it [19]. These studies indicate that tendons are not static structures but rather maintain functional stability through a small diurnal dynamic pool of ECM. CR disruption and musculoskeletal disorders Given the tissue-specific circadian rhythms present in the musculoskeletal system, disruptions to circadian homeostasis are bound to lead to pathological changes. This section will therefore focus on exploring the link between circadian rhythm disruption and musculoskeletal disorders. A thorough understanding of this field will provide significant opportunities for the treatment and prevention of musculoskeletal disorders. Table 1 summarises the characteristics of circadian rhythms in bone, cartilage, muscle and tendon tissues.Table 1CR in bone, cartilage, muscle and tendon.Table 1TissuesCore clock genesFunctional consequencesOscillation characteristicsDisease associationsRefsBoneBMAL1, CLOCL, PER/CRY, REV-ERBInvolved in bone remodelling, the balance between bone formation and resorption, mineralization, and stem cell homeostasis.Most bone metabolism markers reach their peak levels at night and their lowest levels during the day.Osteoporosis[10] [57] [58] [80] [81] [82]CartilageBMAL1, PER/CRYInvolved in the synthesis and degradation of ECM, cartilage repair, and inflammatory responsesThe synthetic activity of chondrocytes peaks at night and reaches its lowest level during the day. The degradative activity of chondrocytes follows the opposite pattern.OA and RA[15] [62] [65] [83] [84]Skeletal MuscleBMAL1, REV-ERBInvolved in muscle growth, development, metabolism and repair.Peak expression of active-phase metabolic genes.Skeletal muscle atrophy and sarcopenia[5] [7] [73] [75] [85] [86]TendonBMAL1Regulates collagen secretion and matrix remodelling, and synergistically regulates ECM metabolism.Peak secretion of active collagen.Tendinopathy[62] [87] [88] [89] Table 1CR in bone, cartilage, muscle and tendon.Table 1TissuesCore clock genesFunctional consequencesOscillation characteristicsDisease associationsRefsBoneBMAL1, CLOCL, PER/CRY, REV-ERBInvolved in bone remodelling, the balance between bone formation and resorption, mineralization, and stem cell homeostasis.Most bone metabolism markers reach their peak levels at night and their lowest levels during the day.Osteoporosis[10] [57] [58] [80] [81] [82]CartilageBMAL1, PER/CRYInvolved in the synthesis and degradation of ECM, cartilage repair, and inflammatory responsesThe synthetic activity of chondrocytes peaks at night and reaches its lowest level during the day. The degradative activity of chondrocytes follows the opposite pattern.OA and RA[15] [62] [65] [83] [84]Skeletal MuscleBMAL1, REV-ERBInvolved in muscle growth, development, metabolism and repair.Peak expression of active-phase metabolic genes.Skeletal muscle atrophy and sarcopenia[5] [7] [73] [75] [85] [86]TendonBMAL1Regulates collagen secretion and matrix remodelling, and synergistically regulates ECM metabolism.Peak secretion of active collagen.Tendinopathy[62] [87] [88] [89] CR in bone, cartilage, muscle and tendon. Osteoporosis Multiple aetiological factors, including ageing, sex hormone deficiency, and prolonged glucocorticoid therapy, are associated with the development of osteoporosis [87]. Interestingly, these factors are all closely associated with disruption of the CR. For instance, “advanced sleep phase” phenomenon is prevalent among the elderly population, making it difficult to maintain continuous sleep, which impairs the synchronizing effect of light signals on the SCN [88]. Moreover, reduced oscillatory expression of core circadian clock proteins was observed in the femur and vertebrae of ovariectomy-induced sex hormone-deficient mice [90]. Similarly, in mouse models, both excessive glucocorticoid administration and the flattening of the glucocorticoid CR have been observed to induce an osteoporotic phenotype [91]. This suggests a close relationship between CR disruption and the osteoporosis phenotype. Numerous clinical epidemiological studies have also confirmed that individuals with CR disorders frequently exhibit pre-osteoporotic characteristics, including reduced bone mass and bone density, altered bone microarchitecture, and diminished bone strength [53,92]. There are multiple pathways that may be involved in the development of osteoporosis resulting from CR disruption (Fig. 3). Firstly, core circadian clock genes (such as BMAL1 and CRY) may participate in regulating bone metabolic homeostasis by directly modulating osteoblast/osteoclast function [93]. For example, Bmal1-knockout osteoblasts exhibit reduced activity, whereas Bmal1 overexpression enhances osteogenic differentiation by activating the Wnt/β-catenin pathway [94,95]. The review by Aoyama et al. has already discussed various circadian gene knockout models established in different bone-associated cells and animals, all of which demonstrate significant effects on bone homeostasis [10]. Specifically, BMAL1, CLOCK, and CRY have been shown to play an active role in bone anabolism, while PER and NOCT predominate in bone catabolism [93].Fig. 3Mechanistic pathways linking CR disruption and osteoporosis. Figures were created with BioRender.com. Mechanistic pathways linking CR disruption and osteoporosis. Figures were created with BioRender.com. Secondly, CR disruption may also disrupt the balance between bone formation and resorption via neuroendocrine pathways. CR indirectly regulates bone metabolism equilibrium by influencing the periodic secretion of melatonin, glucocorticoids, and parathyroid hormone (PTH)[[80], [81], [82]]. Under physiological conditions, these hormones regulate normal bone homeostasis. Melatonin receptor 2 is expressed in mesenchymal stem cells, osteoblasts, and osteoclasts [81]. Research indicates that melatonin promotes the osteogenic differentiation of MSCs, enhances the proliferation and differentiation of osteoblasts, and inhibits osteoclast formation [81]. Meanwhile, PTH exerts an anabolic effect on bone tissue, but when secreted in excess, it induces a catabolic effect [82]. Moreover, glucocorticoids are steroid hormones responsive to CR, directly regulating bone homeostasis in a cell-type-specific manner via glucocorticoid receptors [80]. Extensive research has demonstrated that disruption of these hormonal secretion rhythms leads to the development of an osteoporotic phenotype [91,82]. Finally, CR disruption may also indirectly regulate bone metabolism through the gut-bone axis and the immune-bone axis, thereby promoting the development of osteoporosis. Studies on mice lacking circadian clock genes and on humans with CR disorders have demonstrated that the composition of the gut microbiota exhibits circadian rhythmicity and is entrained by the host's CR[[96], [97], [98]]. Concurrently, immune cells (such as neutrophils and T cells) also exhibit intrinsic CR, and their maturation, migration, and metabolism are regulated by clock genes including BMAL1 and CLOCK. The gut-bone axis theory proposes that the gut microbiota and its metabolites significantly influence bone metabolism via immune and endocrine pathways, and dysbiosis is closely linked to osteoporosis [99]. The concept of the bone-immune system elucidates the bidirectional regulatory mechanism between immune cells and bone cells, demonstrating the regulatory role of the immune-bone axis in bone metabolism [100]. Consequently, dysregulation of gut microbiota and immune cell function resulting from CR disruption may disrupt bone homeostasis via the gut-bone axis and immune-bone axis, thereby inducing an osteoporosis phenotype. Research in this field remains relatively scarce, and further studies are still required to substantiate this view. Arthritis Joint tissues are highly regulated by mechanical forces, and their activity and rest follow a CR governed by the brain's 24-h cycle [12]. Multiple factors, such as ageing and inflammation, may disrupt the homeostasis of joint tissues by impairing CR. In vitro and in vivo experiments confirm that the upregulation of inflammatory cytokines (such as IL-6 and IL-1β) can alter the expression levels of core circadian clock genes and disrupt the cartilage circadian clock, leading to degradation of the cartilage matrix [101,102]. Furthermore, the process of ageing is associated with a decline in the precision of CR, resulting in a misalignment between the body's activity cycles (which are governed by the brain's biological clock) and the optimal circadian phases of joint tissues (which are determined by local biological clocks) [12]. Consequently, joint tissues exhibit an inappropriate response to rhythmic stimuli, such as mechanical loads associated with routine movement or other systemic cues [12]. This state of disconnection has been shown to significantly increase the risk of injury, which is a key precipitating factor in the development of arthritis. A plethora of clinical epidemiological studies have identified a correlation between shift work and an increased risk of osteoarthritis (OA) and rheumatoid arthritis (RA) [103]. In terms of clinical symptoms, both OA and RA exhibit rhythmic characteristics. Pain and inflammation in OA patients gradually worsen during daytime activities and generally lessen in the evening and nighttime hours [104]. The primary symptoms of rheumatoid arthritis, such as joint pain and stiffness, may be regulated by the CR of cytokine and hormone levels, manifesting most prominently in the early morning hours before gradually subsiding [6]. This temporal dynamic of cytokine secretion and joint symptoms is governed by circadian regulation at multiple levels: systemically through time-dependent modulation of signalling pathways, and locally through the concerted action of intrinsic rhythmic systems within inflammatory cells and their pro-inflammatory microenvironments [105]. Multiple mechanisms may be involved in the disruption of the CR and the onset of arthritis (Fig. 4). Firstly, core circadian clock genes participate in the circadian regulation of joint inflammation and cartilage damage by directly modulating the functions of synovial cells, chondrocytes, and immune cells [6]. The absence of BMAL1 in chondrocytes has been shown to disrupt the CR of cartilage, leading to progressive degeneration and lesions in the cartilage [106]. Moreover, disruption of the CR of core clock genes CRY2 and RORA has been observed in synovial fibroblasts from patients with RA [107]. This phenomenon may be attributed to a desynchronization between the central biological clock and the local synovial clock, which may result in altered responsiveness to inflammatory mediators. However, the predominant cell type responsible for the CR oscillations in the pathological changes of RA remains unclear at present.Fig. 4Mechanistic pathways linking CR disruption and arthritis. Figures were created with BioRender.com. Mechanistic pathways linking CR disruption and arthritis. Figures were created with BioRender.com. Secondly, disruption of the CR indirectly induces localized joint inflammation and impairs metabolic equilibrium by modulating the periodic secretion of hormones. Hossain et al. have conducted a review of the influence that different levels of circadian clock-regulating hormones, including melatonin, TSH, and cortisol, have on the pathogenesis of OA [108]. Imbalances in these hormones may lead to cartilage erosion, synovial inflammation, and osteophyte formation by altering the expression of pro-inflammatory cytokines and degenerative enzymes within articular cartilage [108]. Moreover, observational studies of patients with RA have found that patients' morning stiffness symptoms are closely associated with elevated pro-inflammatory cytokines at night and insufficient cortisol secretion [83]. This may be attributed to CR disruption causing irregularities in melatonin and cortisol secretion patterns. Consequently, melatonin promotes inflammatory responses during the night by activating the NF-κB pathway, while the delayed morning peak of cortisol leads to diminished anti-inflammatory effects. Finally, CR disruption may also indirectly regulate the joint microenvironment via the gut-joint axis, thereby exacerbating the pathological progression of RA and OA. Previous studies have confirmed that the gut microbiota exhibits CR, and its metabolites (such as short-chain fatty acids and lipopolysaccharides) can regulate systemic immunity via the intestinal barrier [96,84]. The gut-joint axis theory posits that the gut microbiota profoundly influences the progression of OA and RA through immune and metabolic pathways [84,109]. Therefore, CR disruption may influence the progression of OA and RA by affecting the gut microbiota via the gut-joint axis. In their seminal study, Ma et al. used a mouse model of RA to investigate the relationship between CR and RA. They found that dietary patterns can promote an increased abundance of Parabacteroides distasonis by influencing on circadian oscillations in the gut microbiota [110]. This bacterium modulates inflammatory rhythms in rheumatoid arthritis by inhibiting the SIRT5-NF-κB pathway in macrophages [110]. Further research is still required in this area to substantiate these findings. Nevertheless, all current evidence supporting the hypothesis that CR dysregulation drives arthritis progression via the gut–joint axis comes from animal studies. As preclinical animal models cannot fully replicate the complex physiological and pathological characteristics of human arthritic diseases, future research should include human observational clinical cohorts and interventional clinical trials. Skeletal muscular atrophy and sarcopenia Recent clinical studies have revealed that irregular working hours and prolonged exposure to light-stimulated environments can lead to a decline in skeletal muscle strength and function, thereby increasing the risk of skeletal muscle atrophy and sarcopenia[[111], [112], [113]]. In multiple genetic clock gene knockout mouse models, studies have confirmed that Bmal1 deficiency leads to muscle atrophy and reduced muscle strength in mice, accompanied by pathological alterations in muscle tissue structure characterized by a decrease in both muscle fibre diameter and number [13,114,115]. Skeletal muscle atrophy is closely related to the quality and quantity of muscle fibres [70]. The reduction in muscle mass and function is closely associated with the onset of sarcopenia and skeletal muscle atrophy. Therefore, disruption of the CR may be a key factor in skeletal muscle atrophy and sarcopenia. Multiple pathways are involved in the mechanisms of muscle atrophy mediated by CR disorders (Fig. 5). Recent studies have indicated that protein synthesis and degradation, satellite cell activation, and mitochondrial quality control may be implicated in the processes of skeletal muscle atrophy triggered by CR abnormalities [116]. Firstly, CR is closely associated with signalling pathways involved in skeletal muscle protein synthesis (such as the PI3K/Akt/mTOR signalling pathway) and degradation (such as the ubiquitin-proteasome system and the autophagolysosomal system) [85,86]. Protein synthesis and degradation in skeletal muscle are closely related to the quality and function of skeletal muscle. Secondly, the proliferation, differentiation, and fusion of satellite cells within skeletal muscle can promote early skeletal muscle growth and development [70]. Relevant literature has reviewed that CR-related regulatory factors may directly participate in the activation of myogenic regulatory factors, thereby promoting skeletal muscle growth through the Wnt, Notch, and TGF-β signalling pathways [18]. Abnormalities or deficiencies in CR-related genes severely impair the activation, differentiation, and fusion of skeletal muscle satellite cells, and the reduction in these processes is a key factor leading to skeletal muscle atrophy [18,117]. Moreover, mitochondrial quality control is crucial for maintaining skeletal muscle quality and function. The circadian clock has been demonstrated to exert regulatory effects on a number of processes related to mitochondrial function, including mitochondrial biogenesis, mitochondrial dynamics, mitochondrial autophagy, and oxidative phosphorylation [18]. CR disruption leads to abnormal accumulation and reduced numbers of mitochondria, resulting in increased cell apoptosis and diminished motility, thereby heightening the risk of muscle atrophy [117]. Furthermore, the association between CR and inflammation has been well documented, with the increased ubiquitination levels resulting from inflammation being identified as a significant factor in the loss of skeletal muscle mass [118]. Research has confirmed that although long-term chronic inflammation within the body may suppress skeletal muscle cell regeneration and even accelerate the loss of skeletal muscle mass [119].Fig. 5Mechanistic pathways linking CR dysfunction to skeletal muscle atrophy and sarcopenia. Figures were created with BioRender.com. Mechanistic pathways linking CR dysfunction to skeletal muscle atrophy and sarcopenia. Figures were created with BioRender.com. As demonstrated in previous studies using mouse models with clock gene deletions, the disruption or attenuation of the CR resulting from the absence of central clock genes has been shown to play a significant role in the pathogenesis of sarcopenia [114]. Similar to muscle atrophy, mitochondrial quality may play a key role in CR-related sarcopenia [113]. Mitochondrial dysfunction and aging have been recognized as key contributors to the pathogenesis of sarcopenia [120,121]. Concurrently, the mitochondria within skeletal muscle are influenced by the biological clock or intrinsic CR, and disruptions to their functional rhythms may play a pivotal role in the pathogenesis of sarcopenia. Tendinopathy Currently, it is unclear whether there is a causal link between disruption to the CR and the onset and progression of tendinopathy, as evidence from both in vivo experiments and humans is limited. Yeung et al. used RNA sequencing to examine the expression of circadian clock genes in tendon tissue from patients with chronic tendinopathy [122]. The study's findings show altered expression of circadian clock genes in tendinopathy cases, suggesting potential impaired CR control of tendons [122]; however, a causal link between biological clock disruption and the clinical progression of tendinopathy has not been established, and direct evidence from human studies remains scarce. Meanwhile, tendon calcification phenotypes were observed in both BMAL1 knockout mice and Clock mutant mice, indicating the role of core CR genes in regulating tendon physiology [59,123]. Although studies in mouse models have firmly established a link between disruption of the peripheral circadian clock and tendon tissue ECM dysregulation, it remains unclear whether CR disruption in individuals would lead to pathological impairment of the chronomatrix [19]. Overall, research into the relationship between disrupted CRs and tendinopathy remains limited. Gathering further in vivo and human evidence to establish a causal link between the two may become a key area of future research. Treatment for musculoskeletal disorders based on CR biology Integrating circadian biology into the treatment of musculoskeletal disorders facilitates the optimized management of such conditions. As previously stated, the coordination between the central biological clock and peripheral biological clocks plays a crucial role in maintaining musculoskeletal health. Consequently, there is an urgent need to develop strategies that preserve the synchronization between the central biological clock and the external environment, while ensuring harmonious coordination between peripheral biological clocks and the central biological clock. Chronotherapy strategies based on CR biology can be categorized into two types (Fig. 6) [6]: one directly targets CR systems, aiming to resynchronize disrupted rhythms (or even preventively mitigate their disruption); the other focuses on optimizing the timing of medication administration to address the specific circadian characteristics of individual patients' clinical biomarkers. These measures include lifestyle adjustments, the use of relevant medications, and modifications to the timing of medication administration.Fig. 6Therapeutic approaches for musculoskeletal disorders based on maintaining circadian rhythmicity. Figures were created with BioRender.com. Therapeutic approaches for musculoskeletal disorders based on maintaining circadian rhythmicity. Figures were created with BioRender.com. Adjust your lifestyle to restore disrupted CR As previously mentioned, the human CR clock coordinates physiological activities over time, synchronizing them with the 24-h rhythms of the environment. This coordination is manifested in cyclical patterns such as light/darkness, rest/activity, and eating/fasting. Behavioural factors, including light exposure, sleep duration, food intake, and exercise, can synchronize or desynchronize these CRs. Therefore, lifestyle modifications may potentially aid in the management of musculoskeletal disorders by restoring disrupted CRs. Light is the primary zeitgeber, and appropriately timed exposure to light can effectively intervene in CR alterations. Research has revealed that continuous exposure to light disrupts the CR of mice, diminishes skeletal muscle function, leads to trabecular bone degeneration, and induces a pro-inflammatory state [112]. These symptoms are alleviated upon restoration to a normal light-dark cycle [112]. This indicates that a regular light-dark cycle is beneficial for maintaining musculoskeletal health. To preserve a normal CR, it is advisable to obtain ample daylight exposure during the earlier hours of the day and to avoid exposure to light sources (including illuminated devices) before bedtime and throughout the night [8]. Moreover, phototherapy (such as the use of low-intensity near-infrared light) is also considered to hold promise in treating musculoskeletal disorders, with its mechanism potentially involving the regulation of circadian clock genes [21,124,125]. An interventional clinical trial conducted by Ip et al. indicates that low-level laser therapy combined with hyaluronic acid injections can prolong the functional lifespan of the knee joint in patients with knee osteoarthritis, compared to conventional physiotherapy [125]. Meanwhile, Peng et al. confirmed that the CR protein Cryptochrome 1 (CRY1) is a key mediator in the promotion of in situ bone regeneration by low-intensity near-infrared light [124]. Previous research indicates that the duration and regularity of sleep are crucial for maintaining the body's normal CR and musculoskeletal health. A large cross-sectional study conducted among children and adolescents found that daytime napping was positively correlated with bone hardness [89]. Conversely, both insufficient and excessive sleep duration, along with poor sleep quality, were associated with reduced bone hardness [89]. Therefore, establishing of fixed bedtimes and rising times will lead to the achievement of stable biological rhythms, from which there will be a demonstrable benefit. Given that mealtimes are a zeitgeber within the CR, time-restricted feeding may present a strategy for synchronizing peripheral clocks with the central clock. The promotion of health through chrononutrition approaches can be achieved via three dimensions of dietary behavior: food intake, eating frequency, and eating timing [126]. It has been shown that night-time fasting promotes bone resorption, while daytime eating has the opposite effect of inhibiting this process [127]. Therefore, regular eating patterns may enhance the rhythmicity of bone remodelling. Concurrently, research confirms that “inappropriate” dietary patterns can modulate CR control genes (CCG), thus altering levels of Atrogin-1, MuRF1, and autophagy, which accelerates skeletal muscle mass loss and reduces skeletal muscle performance [18]. Alterations in dietary composition, timing, and frequency lead to abnormal changes in gene expression and circadian rhythmicity within skeletal muscle, thereby impairing skeletal muscle function [18]. Therefore, adjusting dietary patterns that influence CR may alleviate skeletal muscle atrophy. Moreover, research findings indicate that the active compounds in certain edible plants may have a regulatory effect on CR, thus alleviating the effects of chronic diseases [128]. Hence, functional foods that can be used for the prevention and treatment of musculoskeletal disorders are also highly anticipated. Within the musculoskeletal system, exercise serves as an extremely vital rhythmic entrainment factor, as musculoskeletal tissues are extensively influenced by mechanical stimuli. Exercise not only synchronizes the CR of musculoskeletal tissues by promoting glucocorticoid release and activating the sympathetic nervous system, but also directly modulates local musculoskeletal CR through mechanical stimulation [10,17]. Research indicates that exercise-mediated CR amplitude and phase may more effectively maintain skeletal muscle mass [76,113]. Pastreo et al. demonstrated that prolonged endurance training can restore the reduced skeletal muscle mitochondrial content caused by mutations in CR genes, suggesting that exercise may rescue skeletal muscle dysfunction resulting from CR abnormalities [129]. However, the effects of exercise on skeletal muscle vary according to intensity, timing, and duration, potentially related to skeletal muscle fibre types and signalling pathways regulating energy supply [130,131]. Compared with random-timing exercise training, fixed-timing maximal isometric voluntary contraction training more effectively enhances skeletal muscle anaerobic capacity [132,133]. Furthermore, in comparison with morning exercise sessions, both afternoon and evening workouts have been shown to enhance aerobic endurance [134]. Similarly, robust evidence indicates that mechanical stimuli regulate local CR within bone, cartilage, and tendons [15,56]. Therefore, by planning the timing, intensity, and duration of appropriate exercise, one can both improve CR disorders and promote musculoskeletal health. Manage medication schedule: chronotherapy The principles of chronobiology posit that the temporal adjustment of therapeutic interventions according to an individual patient's CR (chronotherapy) can optimize therapeutic outcomes. Chronotherapy indicates that drug administration should be synchronized with the body's CR to maximize therapeutic efficacy while reducing the dosage and minimizing adverse effects [135,136]. Therefore, to achieve this objective, the pharmacodynamic and pharmacokinetic characteristics of the drug formulation have been strategically timed during its design process to align with the body's inherent CR [137,138]. Within musculoskeletal system tissues, the rhythmic characteristics observed across multiple pathways suggest that the targets of numerous drugs may exhibit rhythmic expression or activity during specific periods of the day. Therefore, in the treatment of musculoskeletal disorders, the administration timing must be carefully considered in relation to the patient's CR and the pharmacokinetics and pharmacodynamics of the drug, as this significantly influences both therapeutic outcomes and the likelihood of adverse reactions. In general, the majority of drugs used to treat musculoskeletal disorders consist of hormones or hormone-derived molecules. The pharmacodynamics of these medications are such that they target fundamental signalling pathways, including, but not limited to, those involved in bone metabolism, the regulation of inflammation, and the modulation of immune responses. The timing of administration significantly influences therapeutic efficacy and adverse reactions because of the effects of pharmacometabolism, pharmacokinetics, and the body's CR. Therefore, in the treatment of musculoskeletal disorders, the principle of time therapy must be fully considered. It is necessary to select the most appropriate treatment timing based on a comprehensive understanding of disease rhythms, while precisely monitoring key progression indicators and determining threshold ranges. Concurrently, consideration should be given to the patient's CR type to enhance the efficacy of medical treatment. Circadian-based clinical strategies in orthopaedics Given the significant CR in bone metabolism, optimizing the timing of drug administration can both enhance efficacy and minimize side effects. A interventional clinical study was conducted to investigate the administration of teriparatide at varying times in postmenopausal women diagnosed with osteoporosis [139]. The study indicates that, compared with administration in the morning, administering teriparatide at bedtime is more effective in correcting abnormal CRs in bone turnover, suppressing pathological nocturnal bone resorption and maximising osteogenic effects [139]. Therefore, when using teriparatide in clinical practice, subcutaneous injection at bedtime should be the preferred method to enable precise, time-optimized treatment. Due to the extremely long half-life of bisphosphonates, chronotherapy is unlikely to significantly improve current standard treatment regimens [140]. However, given circadian variations in intestinal absorption, chronotherapy could enhance their poor oral bioavailability [141]. Furthermore, research has revealed that in chronic inflammatory diseases such as OA and RA, the numbers of inflammatory cells and immune response mediators exhibit rhythmic fluctuations [21]. Immune processes, such as the synthesis and release of cytokines and chemokines, immune cell recruitment, phagocytosis, cytolytic activity, and proliferative responses to pathogen antigens, all reach their peak during the late night hours [21]. A randomised controlled clinical trial was conducted to compare the effects of administering glucocorticoids at 2:00 am versus 7:30 am on the improvement of RA symptoms in patients with the condition [142]. The study confirmed that, compared with the traditional practice of administering medication in the early morning, administering it at 2:00 am can bring forward the suppression of the nocturnal IL-6 inflammatory peak, thereby significantly improving morning stiffness and joint symptoms [142]. This provides key, early clinical evidence for the use of circadian hormone therapy and sustained-release formulations in the treatment of rheumatoid arthritis RA. Moreover, a double-blind, interventional clinical trial examining the use of scheduled indomethacin dosing in patients with OA demonstrated that scheduled dosing enhances both the tolerance to and the analgesic efficacy of indomethacin in patients with OA [143]. Furthermore, for shift workers undergoing orthopaedic surgery, CR disruption caused by shift work is a significant yet frequently overlooked perioperative risk factor. Abnormalities in hormone secretion, bone metabolism, inflammatory responses and coagulation homeostasis resulting from CR disruption have the potential to affect multiple aspects of the perioperative period, including preoperative baseline function, intraoperative safety, postoperative recovery and long-term functional prognosis. Prior to surgery, long-term CR disruption has been associated with reduced bone mineral density and an increased baseline risk of fracture. These findings are of particular significance in orthopaedic surgery, as both implant fixation and fracture healing require the skeleton to remain stable. During surgery, disruption of the body's natural 24-h rhythm can affect the absorption and mode of action of anaesthetic drugs, leading to increased dosages, delayed recovery and exacerbated blood pressure instability. Postoperatively, the combination of an intensified perioperative inflammatory storm and disrupted immune rhythms increases the risk of surgical site infections and delays wound healing. In the long term, persistent disruption of the peripheral skeletal CR and muscle repair rhythms impedes fracture healing, increases the incidence of non-union and implant failure, and prolongs the time required for functional recovery. Consequently, the timing of rehabilitation following orthopaedic surgery should be synchronized with the endogenous 24-h circadian rhythm that regulates fundamental healing processes, including the inflammatory response, pain perception, bone remodelling and soft tissue regeneration. The concept of ‘timed rehabilitation’ involves implementing a balanced daily regimen that incorporates both passive and active activities during the day, whilst strategically avoiding high-intensity training at night. This approach aims to strike a balance between mechanical stress stimulation and the protective effects of nocturnal regenerative processes. Conclusion and future perspectives CR is closely associated with human sleep-wake, rest-activity, and eating-fasting cycles. It also regulating the rhythmic activities of the nervous and endocrine systems. Within the musculoskeletal system, most aspects of the physiology and pathophysiology of bone, cartilage, muscle, and tendon are governed by CR. Multiple environmental and behavioural factors, including light exposure, feeding, and physical activity, coordinate the synchronized operation of the body's CR through the sympathetic nervous system and endocrine system. Concurrently, the intrinsic timing system within the musculoskeletal system can provide a temporal framework for its behavioural, physiological, and metabolic activities in the absence of external signals. Under physiological conditions, the core clock genes, hormonal metabolism, the gut-joint axis, and immune pathways coordinate their actions to regulate musculoskeletal homeostasis and repair. The expression of core clock genes in skeletal muscle tissue exhibits tissue specificity and temporal regulation. Their function extends beyond that of mere “timekeeping” tools; their expression levels are also tightly coupled with the functional state of skeletal muscle tissue (bone metabolism, cartilage homeostasis, muscle regeneration). For example, BMAL1, as a key circadian transcription factor, exhibits tissue-specific phenotypes when its expression is disrupted in bone, cartilage, tendon and skeletal muscle tissues. In bone tissue, BMAL1 deficiency primarily leads to inhibited bone formation and enhanced bone resorption, resulting in systemic low bone mass and disruption of bone microstructure. In cartilage, BMAL1 deficiency consistently leads to progressive degeneration, chondrocyte apoptosis and the premature onset of osteoarthritic lesions. In tendons, BMAL1 deficiency results in distinctive pathological ectopic calcification, disruption of collagen fibre architecture and reduced mechanical toughness. In skeletal muscle, BMAL1 deficiency leads to marked atrophy, reduced muscle strength, mitochondrial dysfunction and impaired satellite cell-driven regeneration. The differences in the effects of BMAL1 deficiency across these four tissue types stem from variations in cell lineage fate, extracellular matrix composition, and the specificity of downstream target gene regulation. These distinct effects highlight the highly tissue-specific nature of peripheral circadian clock function; consequently, musculoskeletal disorders associated with CR disruption require precise, targeted interventions rather than global regulation of the circadian clock. Research in this field has identified novel CR regulatory targets for both the prevention (such as daily routines adjustments and phototherapy) and treatment (such as melatonin and agonists targeting CR genes) of musculoskeletal disorders. Looking ahead, research into circadian biology within the field of orthopaedics is set to reshape the prevention of orthopaedic conditions, the timing of surgery, pharmacological treatment, and rehabilitation strategies. In the field of prevention, precise interventions can be achieved by capitalizing on CRs. By taking steps such as exercising regularly, eating a balanced diet and getting enough sleep, it is possible to align with the physiological rhythms that govern tissue repair, inflammatory responses, and bone metabolism. This reduces the risk of developing musculoskeletal disorders. In terms of the timing of surgery, circadian medicine facilitates the scheduling of orthopaedic procedures during the optimal circadian window. This approach utilizes diurnal variations in immune function, coagulation and cellular repair mechanisms to minimize peri-operative complications, alleviate pain, and accelerate early tissue healing. In pharmacotherapy, adopting CR will transform the administration of orthopaedic medications, including a variety of drugs such as anti-inflammatories, analgesics, and bone-modifying agents. Dosing regimens timed to an individual's CR can enhance therapeutic efficacy and reduce adverse effects. Finally, in the field of rehabilitation, circadian medicine will guide the development of personalized rehabilitation programmes, ensuring that physiotherapy, occupational therapy, and rest periods are aligned with the body's CR. These programmes will optimize muscle strength, range of motion, and tissue remodelling, thereby shortening the rehabilitation period. However, despite recent research on molecular clock genes in musculoskeletal tissue, which has deepened our understanding of the link between CR disorders and musculoskeletal diseases, our knowledge of the circadian biology of the musculoskeletal system remains just the tip of the iceberg. In the future, there are still many issues that require urgent attention. Firstly, Science the majority of clock-regulated genes and pathways in the musculoskeletal system show tissue specificity, further investigation into tissue-specific clock target genes/pathways will enhance our understanding of how CR regulates musculoskeletal health and disease. Secondly, due to the differences in CR between humans and nocturnal animals, certain CR modulators may have markedly different divergent physiological effects in the two species. Future research on CR should carefully consider this point, and it is necessary to analyze its core mechanisms to better bridge the gap between animal models and human clinical applications. Concurrently, given the experimental limitations and ethical constraints related to in vivo tissue sectioning, future research urgently needs the development and validation of indirect methods that allow time-series analysis of human tissue in the living organism. Finally, although limited research indicates that optimizing CR may improve musculoskeletal health, the extent of its therapeutic effect for individuals with musculoskeletal disorders remains to be determined. Credit author statement Sheng Zhong: Conceptualization, Investigation, Writing - original draft, Writing - review editing. Yuan Cheng: Conceptualization, Supervision, Writing - review editing. Fadong Li: Writing - review editing, Supervision. Dingpeng Li: Writing - review editing, Supervision. Xudong Chang: Writing - review editing. Bo Zhang: Writing - review editing. Peng Qi: Writing - review editing. Ning Li: Supervision, Writing - review editing. Xingwen Xie: Funding acquisition, Project administration. Declaration of generative AI in scientific writing No generative artificial intelligence (AI) or AI-assisted technologies were used in the preparation of this manuscript. Funding This work was supported by the Key Project of Traditional Chinese Medicine Research in Gansu Province (grant number: GZKZ-2024-9); Key Research Project of Traditional Chinese Medicine in Gansu Province (grant number: GZKZ-2020-6); Major Science and Technology Special Project Plan of Gansu Province (grant number: 22ZD6FA021-4); 10.13039/501100007764Lanzhou Municipal Science and Technology Plan Project (grant number: 2024-2-26); Research Project of Higher Education Institutions in Gansu Province (grant number: 2026CYZC-053). Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.